Literature DB >> 6289384

Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.

M R Brown, L A Fisher, J Spiess, J Rivier, C Rivier, W Vale.   

Abstract

Corticotropin-releasing factor (CRF), a peptide isolated from ovine hypothalamus, and sauvagine, a peptide isolated from frog skin, share significant structural homology and elicit a number of similar biological responses. CRF is more potent than sauvagine in stimulating pituitary ACTH secretion. Sauvagine, however, is 5-10 times more potent than CRF to act within the brain to increase plasma levels of catecholamines and glucose and to elevate mean arterial pressure. Sauvagine is likewise more potent than CRF to act outside the brain to increase superior mesenteric artery flow and plasma glucose concentrations and to decrease mean arterial pressure. CRF and sauvagine produce important effects representative of biologically active peptides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289384     DOI: 10.1016/0167-0115(82)90101-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

1.  Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis.

Authors:  Kendall M Carlin; Wylie W Vale; Tracy L Bale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.

Authors:  Tracy L Bale; Frank J Giordano; Reed P Hickey; Yan Huang; Anjali K Nath; Kirk L Peterson; Wylie W Vale; Kuo-Fen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

Authors:  D N Orth; R V Jackson; G S DeCherney; C R DeBold; A N Alexander; D P Island; J Rivier; C Rivier; J Spiess; W Vale
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

4.  Characterization of rat hypothalamic corticotropin-releasing factor.

Authors:  J Rivier; J Spiess; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

Review 5.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

6.  Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.

Authors:  D M Barker; R Corder
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.

Authors:  C Rivier; W Vale
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Sauvagine-like and corticotropin-releasing factor-like immunoreactivity in the brain of the bullfrog (Rana catesbeiana).

Authors:  G C Gonzalez; K Lederis
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

9.  Hypotensive effects of ovine and human corticotrophin-releasing factors in man.

Authors:  A R Hermus; G F Pieters; J J Willemsen; H A Ross; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Corticotropin releasing factor in neuroplasticity.

Authors:  Limor Regev; Tallie Z Baram
Journal:  Front Neuroendocrinol       Date:  2013-10-19       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.